Cargando…

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia

BACKGROUND: Several countries are implementing a transition to HPV testing for cervical screening in response to the introduction of HPV vaccination and evidence indicating that HPV screening is more effective than cytology. In Australia, a 2017 transition from 2-yearly conventional cytology in 18–2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simms, Kate T., Hall, Michaela, Smith, Megan A., Lew, Jie-Bin, Hughes, Suzanne, Yuill, Susan, Hammond, Ian, Saville, Marion, Canfell, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240951/ https://www.ncbi.nlm.nih.gov/pubmed/28095411 http://dx.doi.org/10.1371/journal.pone.0163509

Ejemplares similares

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia
por: Hall, Michaela T., et al.
Publicado: (2018)

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use
por: Smith, Megan A., et al.
Publicado: (2016)

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
por: Lew, Jie-Bin, et al.
Publicado: (2016)

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study
por: Smith, Megan A, et al.
Publicado: (2022)

Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
por: Smith, Megan A., et al.
Publicado: (2017)

Expenditure and resource utilisation for cervical screening in Australia
por: Lew, Jie-Bin, et al.
Publicado: (2012)

The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support
por: Keane, Adam, et al.
Publicado: (2021)

A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia
por: Nickson, Carolyn, et al.
Publicado: (2023)

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia
por: Canfell, Karen, et al.
Publicado: (2018)

The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study
por: Hall, Michaela T., et al.
Publicado: (2020)

Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years
por: Creighton, Prudence, et al.
Publicado: (2010)

Development and application of a framework to estimate health care costs in China: The cervical cancer example
por: Liu, Yi-Jun, et al.
Publicado: (2019)

Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea
por: Nguyen, Diep Thi Ngoc, et al.
Publicado: (2022)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Self‐collection for HPV screening: a game changer in the elimination of cervical cancer
por: Canfell, Karen, et al.
Publicado: (2021)

Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia
por: Aminisani, Nayyereh, et al.
Publicado: (2012)

Implementation of Australia’s renewed cervical screening program: Preparedness of general practitioners and nurses
por: Sultana, Farhana, et al.
Publicado: (2020)

The experience of under-screened and never-screened participants using clinician-supported self-collection cervical screening within the Australian National Cervical Screening Program
por: Creagh, Nicola S, et al.
Publicado: (2022)

Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study
por: Shi, Ju-Fang, et al.
Publicado: (2011)

Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia
por: Sultana, Farhana, et al.
Publicado: (2014)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening
por: Velentzis, Louiza S., et al.
Publicado: (2023)

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical
por: Mittendorf, Thomas, et al.
Publicado: (2007)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Brisson, Marc, et al.
Publicado: (2020)

The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study
por: Bavor, Claire, et al.
Publicado: (2023)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador
por: Campos, Nicole G., et al.
Publicado: (2019)

Need for expanded HPV genotyping for cervical screening()
por: Cuzick, Jack, et al.
Publicado: (2016)

Cervical Cancer Screening and HPV Vaccination in Nepal
por: Baral, Gehanath, et al.
Publicado: (2023)

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
por: Canfell, Karen, et al.
Publicado: (2017)

Yes! To Scaling Up Cervical Cancer Screening With Self-Collection: But the Cost of HPV Screening Must Be Reduced
por: Beddoe, Ann Marie
Publicado: (2021)

The Implementation of a Primary HPV Self-Testing Cervical Screening Program in Malaysia through Program ROSE—Lessons Learnt and Moving Forward
por: Woo, Yin Ling, et al.
Publicado: (2022)

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
por: Naber, Steffie K., et al.
Publicado: (2016)

Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua
por: Campos, Nicole G, et al.
Publicado: (2017)

Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden
por: Fogelberg, Sara, et al.
Publicado: (2020)

Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
por: Figueiredo, Daniel, et al.
Publicado: (2023)

Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study
por: Brotherton, Julia M.L., et al.
Publicado: (2023)

Proposal for cervical cancer screening in the era of HPV vaccination
por: Ouh, Yung-Taek, et al.
Publicado: (2018)

False positive cervical HPV screening test results
por: Schiffman, Mark, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fnfdlu9ootmh226hgj7eiljgkh